ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2022

Healthcare Resource Utilization and Costs for Empagliflozin Versus Glucagon-Like Peptide-1 Receptor Agonists in Routine Clinical Care in Denmark.

Reimar W Thomsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.